ClinicalTrials.gg

Program

Chorionic Gonadotropin

Also written as “hCG”, “HCG injection” and “Pregnyl: Human chorionic gonadotrophin”.

Its studies are mostly in Hypogonadism · Infertility · Infertility, Female, led by 3 companies.

Furthest: phase 4, since Oct 16, 20124 company-led studies, 1 open or runningNext primary completion: Dec 31, 2027 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Organon20 open or runningphase 3since Oct 16, 2012Oct 16, 2012none ahead
Fertility Center of Las Vegas11 open or runningphase 4since May 27, 2025May 27, 2025Dec 31, 2027phase 4 · NCT07004192
Genuine Research Center, Egypt10 open or runningphase 4since Sep 22, 2020Sep 22, 2020none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 16, 2012First study: phase 3 study in HypogonadismNew to OrganonOrganon · NCT01709331 · 18 enrolled
  2. Jan 11, 2017Phase 3 study in HypogonadismOrganon · NCT03019575 · 17 enrolled · Brazil, Denmark, Italy and more
  3. Sep 22, 2020Genuine Research Center, Egypt's first study: phase 4 study in Infertility, FemaleNew to Genuine Research Center, EgyptGenuine Research Center, Egypt · NCT04605107 · 60 enrolled · Egypt
  4. May 27, 2025Fertility Center of Las Vegas's first study: phase 4 study in InfertilityNew to Fertility Center of Las VegasFertility Center of Las Vegas · NCT07004192 · 220 planned · United States

Ahead

  1. Dec 31, 2027Primary completion: phase 4 study in InfertilityFertility Center of Las Vegas · NCT07004192

TargetBeta

LHCGR →read by rule
“Luteinizing hormone/Choriogonadotropin receptor agonist”ChEMBL 37, by rule

Other programs on LHCGR

ProgramCompanyFurthest phaseStudies
lutropin alfaruleMerck KGaA, Darmstadt, Germanyphase 49

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07004192Infertility · United States4RecruitingFertility Center of Las VegasDec 31, 2027220
NCT04605107Infertility, Female · Egypt4CompletedGenuine Research Center, EgyptJan 8, 201560
NCT03019575Hypogonadism · Brazil, Denmark, Italy and more3CompletedOrganonMay 5, 202017
NCT01709331Hypogonadism3CompletedOrganonApr 8, 201518

How it is read

Names in the registry

  • “hCG”, 2 entries
  • “HCG injection”, 1 entry
  • “Pregnyl: Human chorionic gonadotrophin”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.